London Daily

Focus on the big picture.
Monday, Jun 29, 2026

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

"I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover. It will certainly be Oxford AstraZeneca, that I will be having," Boris Johnson said .

British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.

Johnson dismissed questions in parliament about why several countries had suspended use of the product developed by the British-Swedish pharmaceutical company with scientists at Oxford University.

But he told lawmakers: "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover.

"It will certainly be Oxford AstraZeneca, that I will be having."

Johnson, 56, is among the next category of people being called for vaccination. The government hopes to have offered it to all adults by July.

Health Secretary Matt Hancock said that timeline remains on track, despite the National Health Service in England warning in a letter to administrators that vaccine supplies will be "significantly constrained" from March 29 for up to a month.

"Vaccine supply is always lumpy and we regularly send out technical letters to the NHS to explain the ups and downs of the supply over the future weeks," Hancock told a news conference, insisting the letter was "standard" practice.

Britain has now given more than 25 million people a first dose of a Covid vaccine -- including 11 million doses of the AstraZeneca jab -- after starting a mass inoculation programme in December last year.

It is also using a jab developed by Pfizer/BioNTech in its rollout programme but recipients do not normally get a choice of vaccines.

Johnson wrote in the Times newspaper that the AstraZeneca vaccine "is safe and works extremely well". Hancock and England's deputy chief medical officer Jonathan Van-Tam echoed that assurance at the press conference.

- Royal intervention -


European countries including France, Spain and Germany are among those who have halted using the jab pending a review by the European Medicines Agency (EMA) amid feared links to blood clots and brain haemorrhages.

Queen Elizabeth II's oldest son and heir, Prince Charles, on Wednesday criticised opposition to coronavirus vaccines.

"Who would have thought, for instance, that in the 21st century that there would be a significant lobby opposing vaccination, given its track record in eradicating so many terrible diseases," he said in an article in the Future Healthcare Journal.

Charles, who has been vocal in advocating the rollout of the vaccine among more reluctant minority communities in Britain, added that the jab had the "potential to protect and liberate some of the most vulnerable in our society from coronavirus".

The 72-year-old Prince of Wales tested positive for coronavirus last year and suffered mild symptoms. He had his first dose of a vaccine in February.

His wife, Camilla, 73, confirmed on Tuesday she had been given the AstraZeneca shot.

"You take what you are given," she said as the couple visited a vaccination centre at a north London mosque, adding that she had suffered no ill-effects.

- 'No evidence' -


Professor Jeremy Brown, from the government's Joint Committee on Vaccination and Immunisation (JCVI), said suspension of the AstraZeneca jab was "not logical".

"There is the concern that what's happening in Europe might make people in the UK less confident in the AstraZeneca vaccine," he told broadcaster ITV.

The EMA, the World Health Organization and Britain's Medicines and Healthcare products Regulatory Agency have all backed the AstraZeneca jab.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

European leaders were angered in January after AstraZeneca announced it was unable to deliver the agreed numbers of jabs to the bloc.

Newsletter

Related Articles

0:00
0:00
Close
UK Launches New Measures to Improve Safety Standards in Night-Time Venues
UK Tightens Import Rules for Low-Value Parcels to Support Domestic Retailers
UK Launches £85 Million Obesity Care Programme Targeting Early Intervention Projects
UK Commits Up to $26 Million to Ebola Response in Democratic Republic of Congo
Security Industry Authority Flags Safety Failures in Night-Time Economy Inspections
Cambridge South Railway Station Opens After £250 Million Investment
UK Moves to Close Import Duty Loophole for Small Parcels by 2028
UK Invests £85 Million in Projects to Transform Obesity Care
Berkeley Group Warns London Housebuilding Falling Far Short of Demand
UK Council Tax Arrears Rise to £9.3 Billion Amid Ongoing Household Financial Strain
Markets Watch Political Transition as Andy Burnham Emerges as Labour Leadership Frontrunner
Extreme Heat Raises Long-Term Risks for UK Inflation and Productivity, Analysts Warn
UK Health Alerts Extended as Record June Heatwave Grips England
UK Parliament Faces High-Stakes Week of Spending, Security and Industrial Legislation
UK Repeals Vagrancy Act Ending Criminalisation of Rough Sleeping in England and Wales
GB News Pundit Charged With Fraud Over Alleged Conduct as Former Labour Adviser
Reform UK Gains Parliamentary Visibility in First Senedd Opposition Appearance
Metropolitan Police Arrest Man on Suspicion of Attempted Murder After London Car Incident
Ocado Chief Executive Tim Steiner Faces Scrutiny Over £100 Million Remuneration Package
British Chambers of Commerce Downgrades UK Growth Outlook to 0.9 Percent for 2026
Nottingham University Hospitals Maternity Failings Trigger Renewed Calls for Public Inquiry
Severe Heatwave Disrupts UK Transport Networks and Strains Public Services Across England
Labour Leadership Transition Raises Prospect of Andy Burnham Becoming UK Prime Minister
UK Government Confirms Further Medicine Price Concessions for Community Pharmacies in June
British Chambers of Commerce Calls for Public Procurement Reform to Boost Regional Growth
Thousands Mark Armed Forces Day Across the United Kingdom With National Parades and Flypasts
Man Arrested in Ealing on Suspicion of Attempted Murder After Vehicle Ramming Incident Injures Five
Cambridge South Station Opens With £250 Million Investment to Strengthen Life Sciences Corridor
UK Heat-Health Alerts Extended Across England as High Temperatures Persist
Thames Water and Energy Operators Warn of Peak Demand Risks During UK Heatwave
Government Conference Highlights Push for Evidence-Led Policy Across UK Public Sector
Insolvency Service Reports Improved Confidence in UK Insolvency System
Security Industry Authority Finds Widespread Safety Failures in UK Night-Time Economy
Nigel Farage Expands Anti-WHO Campaign Into United States With New Lobbying Structure
Home Secretary Seema Mahmood Unveils New Safe Routes Plan for Asylum Seekers
UK Government Warns of Peak Electricity and Water Pressure Amid Ongoing Heatwave
New Nuclear Plant in Wales Named Gwyndod Power Station as Energy Strategy Advances
UK Announces First Major Hydropower Projects in Four Decades to Expand Renewable Capacity
Thirteen Men Charged in Major UK Sexual Abuse Case as Investigation Continues
UK Launches Cross-Sector Climate Security Taskforce Linking Environment and National Security
UN Secretary-General António Guterres Calls for Urgent Global Methane Emissions Cuts in London
World Bank Approves $1 Billion UK-Backed Financing Package for Ukraine Recovery
UK Pledges Emergency Aid and Rescue Team Deployment to Earthquake-Hit Venezuela
Bank of England Holds Interest Rates at 3.75 Percent for Fourth Straight Meeting
Record-Breaking Heatwave Puts Strain on UK Health Services and Energy Networks
London Ambulance Service Sees Record Emergency Demand as Heatwave Intensifies
British Chambers of Commerce Warns of Prolonged Weak Investment Climate Through 2027
Bank of England Holds Interest Rates as Inflation Risks Persist
UK Construction Sector Faces One Percent Contraction Amid Cost and Investment Pressures
Former DUP Leader Sir Jeffrey Donaldson Convicted of Sexual Offences
×